Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cerebrovascular Disease Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Carotid Endarterectomy
1.2.3 Carotid Angioplasty Or Carotid Artery Stenting
1.2.4 Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
1.3 Market by Application
1.3.1 Global Cerebrovascular Disease Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Academic & Research Institutes
1.3.3 Pharmaceutical & Biotechnology Companies
1.3.4 Hospitals & Diagnostic Centers
1.3.5 Contract Research Organizations
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cerebrovascular Disease Market Perspective (2018-2033)
2.2 Cerebrovascular Disease Growth Trends by Region
2.2.1 Global Cerebrovascular Disease Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Cerebrovascular Disease Historic Market Size by Region (2018-2023)
2.2.3 Cerebrovascular Disease Forecasted Market Size by Region (2024-2033)
2.3 Cerebrovascular Disease Market Dynamics
2.3.1 Cerebrovascular Disease Industry Trends
2.3.2 Cerebrovascular Disease Market Drivers
2.3.3 Cerebrovascular Disease Market Challenges
2.3.4 Cerebrovascular Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cerebrovascular Disease Players by Revenue
3.1.1 Global Top Cerebrovascular Disease Players by Revenue (2018-2023)
3.1.2 Global Cerebrovascular Disease Revenue Market Share by Players (2018-2023)
3.2 Global Cerebrovascular Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cerebrovascular Disease Revenue
3.4 Global Cerebrovascular Disease Market Concentration Ratio
3.4.1 Global Cerebrovascular Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cerebrovascular Disease Revenue in 2022
3.5 Cerebrovascular Disease Key Players Head office and Area Served
3.6 Key Players Cerebrovascular Disease Product Solution and Service
3.7 Date of Enter into Cerebrovascular Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cerebrovascular Disease Breakdown Data by Type
4.1 Global Cerebrovascular Disease Historic Market Size by Type (2018-2023)
4.2 Global Cerebrovascular Disease Forecasted Market Size by Type (2024-2033)
5 Cerebrovascular Disease Breakdown Data by Application
5.1 Global Cerebrovascular Disease Historic Market Size by Application (2018-2023)
5.2 Global Cerebrovascular Disease Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Cerebrovascular Disease Market Size (2018-2033)
6.2 North America Cerebrovascular Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Cerebrovascular Disease Market Size by Country (2018-2023)
6.4 North America Cerebrovascular Disease Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cerebrovascular Disease Market Size (2018-2033)
7.2 Europe Cerebrovascular Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Cerebrovascular Disease Market Size by Country (2018-2023)
7.4 Europe Cerebrovascular Disease Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cerebrovascular Disease Market Size (2018-2033)
8.2 Asia-Pacific Cerebrovascular Disease Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Cerebrovascular Disease Market Size by Region (2018-2023)
8.4 Asia-Pacific Cerebrovascular Disease Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cerebrovascular Disease Market Size (2018-2033)
9.2 Latin America Cerebrovascular Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Cerebrovascular Disease Market Size by Country (2018-2023)
9.4 Latin America Cerebrovascular Disease Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cerebrovascular Disease Market Size (2018-2033)
10.2 Middle East & Africa Cerebrovascular Disease Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Cerebrovascular Disease Market Size by Country (2018-2023)
10.4 Middle East & Africa Cerebrovascular Disease Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Cerebrovascular Disease Introduction
11.1.4 Johnson & Johnson Revenue in Cerebrovascular Disease Business (2018-2023)
11.1.5 Johnson & Johnson Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Cerebrovascular Disease Introduction
11.2.4 Amgen Revenue in Cerebrovascular Disease Business (2018-2023)
11.2.5 Amgen Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Cerebrovascular Disease Introduction
11.3.4 GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2018-2023)
11.3.5 GlaxoSmithKline Recent Development
11.4 Sanofi-Aventis
11.4.1 Sanofi-Aventis Company Detail
11.4.2 Sanofi-Aventis Business Overview
11.4.3 Sanofi-Aventis Cerebrovascular Disease Introduction
11.4.4 Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2018-2023)
11.4.5 Sanofi-Aventis Recent Development
11.5 Merck
11.5.1 Merck Company Detail
11.5.2 Merck Business Overview
11.5.3 Merck Cerebrovascular Disease Introduction
11.5.4 Merck Revenue in Cerebrovascular Disease Business (2018-2023)
11.5.5 Merck Recent Development
11.6 Sangamo BioSciences
11.6.1 Sangamo BioSciences Company Detail
11.6.2 Sangamo BioSciences Business Overview
11.6.3 Sangamo BioSciences Cerebrovascular Disease Introduction
11.6.4 Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2018-2023)
11.6.5 Sangamo BioSciences Recent Development
11.7 Aldagen
11.7.1 Aldagen Company Detail
11.7.2 Aldagen Business Overview
11.7.3 Aldagen Cerebrovascular Disease Introduction
11.7.4 Aldagen Revenue in Cerebrovascular Disease Business (2018-2023)
11.7.5 Aldagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cerebrovascular Disease Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Carotid Endarterectomy
Table 3. Key Players of Carotid Angioplasty Or Carotid Artery Stenting
Table 4. Key Players of Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
Table 5. Global Cerebrovascular Disease Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Cerebrovascular Disease Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Cerebrovascular Disease Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Cerebrovascular Disease Market Share by Region (2018-2023)
Table 9. Global Cerebrovascular Disease Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global Cerebrovascular Disease Market Share by Region (2024-2033)
Table 11. Cerebrovascular Disease Market Trends
Table 12. Cerebrovascular Disease Market Drivers
Table 13. Cerebrovascular Disease Market Challenges
Table 14. Cerebrovascular Disease Market Restraints
Table 15. Global Cerebrovascular Disease Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Cerebrovascular Disease Market Share by Players (2018-2023)
Table 17. Global Top Cerebrovascular Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cerebrovascular Disease as of 2022)
Table 18. Ranking of Global Top Cerebrovascular Disease Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Cerebrovascular Disease Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cerebrovascular Disease Product Solution and Service
Table 22. Date of Enter into Cerebrovascular Disease Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cerebrovascular Disease Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Cerebrovascular Disease Revenue Market Share by Type (2018-2023)
Table 26. Global Cerebrovascular Disease Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global Cerebrovascular Disease Revenue Market Share by Type (2024-2033)
Table 28. Global Cerebrovascular Disease Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Cerebrovascular Disease Revenue Market Share by Application (2018-2023)
Table 30. Global Cerebrovascular Disease Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global Cerebrovascular Disease Revenue Market Share by Application (2024-2033)
Table 32. North America Cerebrovascular Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America Cerebrovascular Disease Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Cerebrovascular Disease Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe Cerebrovascular Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe Cerebrovascular Disease Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Cerebrovascular Disease Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific Cerebrovascular Disease Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific Cerebrovascular Disease Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Cerebrovascular Disease Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America Cerebrovascular Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America Cerebrovascular Disease Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Cerebrovascular Disease Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa Cerebrovascular Disease Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa Cerebrovascular Disease Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Cerebrovascular Disease Market Size by Country (2024-2033) & (US$ Million)
Table 47. Johnson & Johnson Company Detail
Table 48. Johnson & Johnson Business Overview
Table 49. Johnson & Johnson Cerebrovascular Disease Product
Table 50. Johnson & Johnson Revenue in Cerebrovascular Disease Business (2018-2023) & (US$ Million)
Table 51. Johnson & Johnson Recent Development
Table 52. Amgen Company Detail
Table 53. Amgen Business Overview
Table 54. Amgen Cerebrovascular Disease Product
Table 55. Amgen Revenue in Cerebrovascular Disease Business (2018-2023) & (US$ Million)
Table 56. Amgen Recent Development
Table 57. GlaxoSmithKline Company Detail
Table 58. GlaxoSmithKline Business Overview
Table 59. GlaxoSmithKline Cerebrovascular Disease Product
Table 60. GlaxoSmithKline Revenue in Cerebrovascular Disease Business (2018-2023) & (US$ Million)
Table 61. GlaxoSmithKline Recent Development
Table 62. Sanofi-Aventis Company Detail
Table 63. Sanofi-Aventis Business Overview
Table 64. Sanofi-Aventis Cerebrovascular Disease Product
Table 65. Sanofi-Aventis Revenue in Cerebrovascular Disease Business (2018-2023) & (US$ Million)
Table 66. Sanofi-Aventis Recent Development
Table 67. Merck Company Detail
Table 68. Merck Business Overview
Table 69. Merck Cerebrovascular Disease Product
Table 70. Merck Revenue in Cerebrovascular Disease Business (2018-2023) & (US$ Million)
Table 71. Merck Recent Development
Table 72. Sangamo BioSciences Company Detail
Table 73. Sangamo BioSciences Business Overview
Table 74. Sangamo BioSciences Cerebrovascular Disease Product
Table 75. Sangamo BioSciences Revenue in Cerebrovascular Disease Business (2018-2023) & (US$ Million)
Table 76. Sangamo BioSciences Recent Development
Table 77. Aldagen Company Detail
Table 78. Aldagen Business Overview
Table 79. Aldagen Cerebrovascular Disease Product
Table 80. Aldagen Revenue in Cerebrovascular Disease Business (2018-2023) & (US$ Million)
Table 81. Aldagen Recent Development
Table 82. Research Programs/Design for This Report
Table 83. Key Data Information from Secondary Sources
Table 84. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cerebrovascular Disease Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Cerebrovascular Disease Market Share by Type: 2022 VS 2033
Figure 3. Carotid Endarterectomy Features
Figure 4. Carotid Angioplasty Or Carotid Artery Stenting Features
Figure 5. Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone) Features
Figure 6. Global Cerebrovascular Disease Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global Cerebrovascular Disease Market Share by Application: 2022 VS 2033
Figure 8. Academic & Research Institutes Case Studies
Figure 9. Pharmaceutical & Biotechnology Companies Case Studies
Figure 10. Hospitals & Diagnostic Centers Case Studies
Figure 11. Contract Research Organizations Case Studies
Figure 12. Others Case Studies
Figure 13. Cerebrovascular Disease Report Years Considered
Figure 14. Global Cerebrovascular Disease Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Cerebrovascular Disease Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Cerebrovascular Disease Market Share by Region: 2022 VS 2033
Figure 17. Global Cerebrovascular Disease Market Share by Players in 2022
Figure 18. Global Top Cerebrovascular Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cerebrovascular Disease as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Cerebrovascular Disease Revenue in 2022
Figure 20. North America Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Cerebrovascular Disease Market Share by Country (2018-2033)
Figure 22. United States Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Cerebrovascular Disease Market Share by Country (2018-2033)
Figure 26. Germany Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Cerebrovascular Disease Market Share by Region (2018-2033)
Figure 34. China Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Cerebrovascular Disease Market Share by Country (2018-2033)
Figure 42. Mexico Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Cerebrovascular Disease Market Share by Country (2018-2033)
Figure 46. Turkey Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Cerebrovascular Disease Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Johnson & Johnson Revenue Growth Rate in Cerebrovascular Disease Business (2018-2023)
Figure 49. Amgen Revenue Growth Rate in Cerebrovascular Disease Business (2018-2023)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Cerebrovascular Disease Business (2018-2023)
Figure 51. Sanofi-Aventis Revenue Growth Rate in Cerebrovascular Disease Business (2018-2023)
Figure 52. Merck Revenue Growth Rate in Cerebrovascular Disease Business (2018-2023)
Figure 53. Sangamo BioSciences Revenue Growth Rate in Cerebrovascular Disease Business (2018-2023)
Figure 54. Aldagen Revenue Growth Rate in Cerebrovascular Disease Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed